Trends of risk classification and primary therapy for Japanese patients with prostate cancer in Nara Uro-Oncological Research Group (NUORG)--a comparison between 2004-2006 and 2007-2009.

Autor:	Nobumichi Tanaka1 sendo@naramed-u.ac.jp, Akihide Hirayama1 hirayamn@naramed-u.ac.jp, Tatsuo Yoneda1 uro-yone@nmu-gw.naramed-u.ac.jp, Katsunori Yoshida1 kappo@nmu-gw.naramed-u.ac.jp, Keiji Shimada2 keijishi@naramed-u.ac.jp, Noboru Konishi2 nkonishi@naramed-u.ac.jp, Kiyohide Fujimoto1 kiyokun@naramed-u.ac.jp, Tanaka, Nobumichi1 (AUTHOR), Hirayama, Akihide (AUTHOR), Yoneda, Tatsuo (AUTHOR), Yoshida, Katsunori (AUTHOR), Shimada, Keiji (AUTHOR), Konishi, Noboru (AUTHOR), Fujimoto, Kiyohide (AUTHOR)
Zdroj:	BMC Cancer. 2013, Vol. 13 Issue 1, p1-14. 14p. 1 Chart, 5 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu